Prescription Opioids and Labor Market Pains: The Effect of Schedule II Opioids on Labor Force Participation and Unemployment

Harris, Matthew and Kessler, Lawrence and Murray, Matthew and Glenn, Beth (2017): Prescription Opioids and Labor Market Pains: The Effect of Schedule II Opioids on Labor Force Participation and Unemployment.

Abstract

We examine the effect of prescription opioids on county labor market outcomes, using data from the Prescription Drug Monitoring Programs of ten U.S. states and labor data from the Bureau of Labor Statistics. We achieve causal identofication by exploiting plausibly exogenous variation in the concentration of high-volume prescribers as instruments (using Medicare Part D prescriber data). We find strong adverse effects on labor force participation rates, employment- to-population ratios, and unemployment rates. Notably, a 10 percent increase in prescriptions causes a 0.56 percentage point reduction in labor force participation, similar to the drop attributed to the 1984 liberalization of Disability Insurance.

• Item Type: MPRA Paper
• Language: English
• Keywords: I12, J21
• Subjects: I - Health, Education, and Welfare > I1 - Health > I12 - Health Behavior; J - Labor and Demographic Economics > J2 - Demand and Supply of Labor > J21 - Labor Force and Employment, Size, and Structure

References

Ashworth, J., D. J. Green, K. M. Dunn, and K. P. Jordan (2013). Opioid use among low back pain patients in primary care: Is opioid prescription associated with disability at 6-month follow-up? PAIN R 154 (7), 1038-1044.

Auld, M. C. (2005). Smoking, drinking, and income. Journal of Human Resources 40, 505-518.

Autor, D. (2015). Why are there still so many jobs. Journal of Economic Perspectives 29 (3), 3-30.

Autor, D. H. and M. G. Duggan (2003). The rise in the disability rolls and the decline in unemployment. The Quarterly Journal of Economics 118 (1), 157-206.

Ballantyne, J. and M. Sullivan (2015). Intensity of chronic pain - the wrong metric? New England Journal of Medicine 373 (22), 2098-2099.

Baum, C. F., M. E. Schaffer, and S. Stillman (2007). Enhanced routines for instrumental variables/GMM estimation and testing. Stata Journal 7 (4), 465-506.

Betses, M. and T. Brennan (2013). Abusive prescribing of controlled substances: a pharmacy view. New England Journal of Medicine 369 (11), 989-991.

Black, D., K. Daniel, and S. Sanders (2002). The impact of economic conditions on participation in disability programs: Evidence from the coal boom and bust. The American Economic Review 92 (1), 27.

Boccuti, C., C. Fields, G. Casillas, and L. Hamel (2015). Primary care physicians accepting medicare: A snapshot.

Boscarino, J. A., M. Rukstalis, S. N. Hoffman, P. M. Han, J. J.and Erlich, G. S. Gerhard, and W. F. Stewart (2010). Risk factors for drug dependence among outpatients on opioid therapy in a large us health care system. Addiction 105 (10), 1776-1782.

Bray, J. W. (2005). Alcohol use, human capital, and wages. Journal of Labor Economics 23, 279-312.

Breusch, T., H. Qian, P. Schmidt, and D. Wyhowski (1999). Redundancy of moment conditions. Journal of Econometrics 91 (1), 89-111.

Buchmueller, T. C. and C. Carey (2018). The effect of prescription drug monitoring programs on opioid utilization in medicare. American Economic Journal: Economic Policy 10 (1) 77-112

Buchmueller, T. C. and S. H. Zuvekas (1998). Drug use, drug abuse, and labor market outcomes. Health Economics 7 (3), 229-245.

Burgess, D. J., M. Crowley-Matoka, S. Phelan, J. F. Dovidio, R. Kerns, C. Roth, S. Saha, and M. vanRyn (2008). Patient race and physicians' decisions to prescribe opioids for chronic low back pain. Social Science and Medicine 67 (11), 1852-1860.

Butikofer, A. and M. M. Skira (2017). Missing work is a pain: The effect of cox-2 inhibitors on sickness absence and disability pension receipt. Journal of Human Resources, Forthcoming.

Chou, R., J. A. Turner, E. B. Devine, R. N. Hansen, S. D. Sullivan, I. Blazina, T. Dana, C. Bougatsos, and R. A. Deyo (2015). The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a national institutes of health pathways to prevention workshop. Annals of Internal Medicine 162 (4), 276-286.

Compton, W. M., C. M. Jones, and G. Baldwin (2016). Relationship between nonmedical prescription-opioid use and heroin use. New England Journal of Medicine 374, 154-163.

Cook, P. and M. J. Moore (1993). Drinking and schooling. Journal of Health Economics 12, 411-429.

Daubresse, M., B. Saloner, H. A. Pollack, and G. Caleb Alexander (2017). Non-buprenorphine opioid utilization among patients using buprenorphine. Addiction.

Davis, P., B. Gribben, A. Scott, and R. Lay-Yee (2000). The `supply hypothesis' and medical practice variation in primary care: testing economic and clinical models of inter-practitioner variation. Social Science & Medicine 50 (3), 407-418.

Department of Health and Human Services (2013). Addressing prescription drug abuse in the United States: Current and future opportunities.

DeSimone, J. (2002). Illegal drug use and employment. Journal of Labor Economics 20 (4), 952-977.

Dhalla, I. A., M. M. Mamdani, T. Gomes, and D. N. Juurlink (2011). Clustering of opioid prescribing and opioid-related mortality among family physicians in ontario. Canadian Family Physician 57 (3), e92-e96.

Drug Enforcement Administration (2014). Schedules of controlled substances: rescheduling of hydrocodone combination products from schedule III to schedule II. Final rule. Federal Register 79 (163), 49661.

Eagles, M., P. Belanger, and H. W. Calkins (2004). The spatial structure of urban political discussion networks. In M. F. Janelle (Ed.), Spatially Integrated Social Science. Oxford University Press.

Erceg, C. J. and A. T. Levin (2014). Labor force participation and monetary policy in the wake of the great recession. Journal of Money, Credit and Banking 46 (S2), 3-49.

FDA (2017). Introduction for the FDA blueprint for prescriber education for extended-release and long-acting opioid analgesics.

FDA (2017). Timeline of selected FDA activities and significant events addressing opioid misuse and abuse.

Firpo, S., N. M. Fortin, and T. Lemieux (2009). Unconditional quantile regressions. Econometrica 77 (3), 953-973.

Franklin, G. M., B. D. Stover, J. A. Turner, D. Fulton- Kehoe, and T. M. Wickizer (2008). Early opioid prescription and subsequent disability among workers with back injuries: the disability risk identification study cohort. Spine 33 (2), 199-204.

French, M. T. and G. A. Zarkin (1995). Is moderate alcohol use related to wages? Journal of Health Economics 14, 319-344.

GAO (2011). Instances of questionable access to prescription drugs.

Garnier, L. M., A. M. Arria, K. M. Caldeira, K. B. Vincent, K. E. O'Grady, and E. D. Wish (2010). Sharing and selling of prescription medications in a college student sample. Journal of Clinical Psychiatry 71 (3), 262-269.

Garthwaite, C. (2012). The economic benefits of pharmaceutical innovations: The case of cox-2 inhibitors. American Economic Journal: Applied Economics 4 (3), 116-137.

Gilson, A. M., K. M. Ryan, D. E. Joranson, and J. L. Dahl (2004). A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 19972002. Journal of Pain and Symptom Management 28 (2), 176-188.

Green, C. R., K. O. Anderson, T. A. Baker, L. C. Campbell, S. Decker, R. B. Fillingim, D. A. Kaloukalani, K. E. Lasch, C. Myers, and R. C. Tait (2003). The unequal burden of pain: confronting racial and ethnic disparities in pain. Pain Medicine 4 (3), 277-294.

Grytten, J. and R. Sorensen (2003). Practice variation and physician-specific effects. Journal of Health Economics 22 (3), 403-418.

Hall, R. E. (2015). Quantifying the lasting harm to the U.S. economy from the financial crisis. NBER Macroeconomics Annual 29 (1), 71-128.

Hansen, L. P. (1982). Large sample properties of generalized method of moments estimators. Econometrica 50, 1029-1054.

Hollingsworth, A., C. J. Ruhm, and K. Simon (2017). Macroeconomic conditions and opioid abuse. NBER Working Paper, #23192.

Huckfeldt, R. R. (1983). Social contexts, social networks, and urban neighborhoods; environmental constrains on friendship choice. American Journal of Sociology 89, 651-669.

Kidner, C. L., T. G. Mayer, and R. J. Gatchel (2009). Higher opioid doses predict poorer functional outcome in patients with chronic disabling occupational musculoskeletal disorders. The Journal of Bone and Joint Surgery. American volume. 91 (4), 919.

Kilby, A. E. (2015). Opioids for the masses: Welfare tradeoffs in the regulation of narcotic pain medications. Working Paper, Northeastern University.

Kliff, S. (2017). The opioid crisis changed how doctors think about pain. Vox.

Krueger, A. B. (2015). Where Have All the Workers Gone? Working Paper, Boston Federal Reserve.

Laird, J. and T. Neilson (2016). The effects of physician prescribing behaviors on prescription drug use and labor supply: evidence from movers in Denmark. Harvard University Working Papers.

Laxmaiah Manchikanti, M., I. Standiford Helm, and J. W. J. MA (2012). Opioid epidemic in the United States. Pain Physician 15, 2150-1149.

Lipari, R. N. and A. Hughes (2017). How people obtain the prescription pain relievers they misuse. Technical report, Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration.

Mahmud, M. A., B. S. Webster, T. K. Courtney, S. Matz, J. A. Tacci, and D. C. Christiani(2000). Clinical management and the duration of disability for work-related low back pain. Journal of Occupational and Environmental Medicine 42 (12), 1178-1187.

McCabe, S. E., M. Morales, J. A. Cranford, J. Delva, M. D. McPherson, and C. J. Boyd (2007). Race/ethnicity and gender differences in drug use and abuse among college students. Journal of Ethnicity in Substance Abuse 6 (2), 75-95.

Meara, E., J. R. Horwitz, W. Powell, L. McClelland, W. Zhou, A. J. O'malley, and N. E. Morden (2016). State legal restrictions and prescription opioid use among disabled adults. New England Journal of Medicine 375 (1), 44-53.

Meier, B. (2010). In guilty plea, oxycontin maker to pay $600 million. New York Times.

Meldrum, M. L. (2003). A capsule history of pain management. Journal of the American Medical Association 290 (18), 2470-2475.

Mok, W., B. Wellman, and R. Basu (2007). Did distance matter before the internet? Social Networks 29 (3), 430-461.

Mok, W., B. Wellman, and J. A. Carrasco (2010). Does distance matter in the age of the internet? Urban Studies 47 (3), 2747-2783.

Morden, N. E., J. C. Munson, C. H. Colla, J. S. Skinner, J. P. Bynum, W. Zhou, and E. R. Meara (2014). Prescription opioid use among disabled medicare beneficiaries: Intensity, trends and regional variation. Medical care 52 (9), 852.

Mularski, R. A., F. White-Chu, D. Oberbay, L. Miller, S. M. Asch, and L. Ganzini (2006).

Measuring pain as the 5th vital sign does not improve quality of pain management. Journal of General Internal Medicine 21 (6), 607-612.

Mullahy, J. and J. Sindelar (1993). Alcoholism, work, and income. Journal of Health Economics 11 (3), 494-520.

Mullahy, J. and J. Sindelar (1996). Employment, unemployment, and problem drinking. Journal of Health Economics 15 (4), 409-434.

Nelson, L., D. Juurlink, and J. Perrone (2015). Addressing the opioid epidemic. Journal of the American Medical Association 314 (14), 1453-1454.

Oregon Health Authority (2012). Prescription drug dispensing in Oregon, October 2011-March 2012. Technical report, Oregon Health Authority.

Patrick, S. W., R. E. Schumacher, B. D. Benneyworth, E. E. Krans, J. M. McAllister, and M. M. Davis (2012). Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009. Journal of the American Medical Association 307 (18), 1934-1940.

Paulozzi, L. J., K. A. Mack, and J. M. Hockenberry (2014). Vital signs: variation among states in prescribing of opioid pain relievers and enzodiazepines in the United States, 2012. MMWR Morb Mortal Wkly Rep 63 (26), 563-8.

Powell, D., R. Pacula, and E. Taylor (2015). How increasing medical access to opioids contributes to the opioid epidemic: evidence from medicare part D. NBER Working Paper, #21072.

Rudd, R. A. (2016). Increases in drug and opioid-involved overdose deaths - United States, 2010-2015. MMWR. Morbidity and mortality weekly report 65.

Sacarny, A., D. Yokum, and S. Agrawal (2017). Government-academic partnerships in randomized evaluations: The case of inappropriate prescribing. American Economic Review Papers & Proceedings 107, 466-470.

SAMHSA (2011). Drug abuse warning network, 2011: National estimates of drug-related emergency department visits, sma13-4760. Technical report, Substance Abuse and Mental Health Services Administration.

SAMHSA (2014). The TEDS report: Gender differences in primary substances of abuse across age groups. Technical report, Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration.

Sargan, J. D. (1958). The estimation of economic relationships using instrumental variables. Econometrica 26, 393-415.

Semuels, A. (2017). The lonely women of the rust belt. The Atlantic.

Shah, A., C. Hayes, and B. Martin (2017). Characteristics of initial prescription episodes and likelihood of long-term opioid use - United States, 2006-2015. MMWR Morbidity and Mortality Weekly Report.

Shavers, V. L., A. Bakos, and V. B. Sheppard (2010). Race, ethnicity, and pain among the U.S. adult population. Journal of Health Care for the Poor and Underserved 21 (1), 177-220.

Song, Z. (2017). Mortality quadrupled among opioid-driven hospitalizations, notably within lower-income and disabled white populations. Health Affairs 36 (12), 2054-2061.

Staiger, D. and J. H. Stock (1997). Instrumental variables regression with weak instruments. Econometrica 65 (3), 557-586.

Surratt, H. L., C. O'Grady, S. P. Kurtz, Y. Stivers, T. J. Cicero, R. C. Dart, and M. Chen (2014). Reductions in prescription opioid diversion following recent legislative interventions in Florida. Pharmacoepidemiology 23, 314-320.

Swedlow, A., J. Ireland, and G. Johnson (2011). Prescribing patterns of schedule II opioids in California workers' compensation. CWCI Technical Report.

Tilly, C. (1982). To Dwell among Friends: Personal Networks in Town and City. Chicago: University of Chicago Press.

Tompkins, D. A., J. G. Hobelmann, and P. Compton (2017). Providing chronic pain management in the fifth vital sign era: Historical and treatment perspectives on a modern-day medical dilemma. Drug and Alcohol Dependence 173, S11-S21.

Volkow, N. D. (2014). Americas addiction to opioids: Heroin and prescription drug abuse. Technical report, Senate Caucus on International Narcotics Control.

Volkow, N. D. and A. T. McLellan (2016). Opioid abuse in chronic pain - misconceptions and mitigation strategies. New England Journal of Medicine 374, 1253-1263.

Wang, Y. R. and M. V. Pauly (2005). Spillover effects of restrictive drug formularies on physician prescribing behavior. Journal of Economics and Management Strategies 14, 755-773.

Webster, B. S., S. K. Verma, and R. J. Gatchel (2007). Relationship between early opioid prescribing for acute occupational low back pain and disability duration, medical costs, subsequent surgery and late opioid use. Spine 32 (19), 2127-2132.

Zacny, J., G. Bigelow, P. Compton, K. Foley, M. Iguchi, and C. Sannerud (2003). College on problems of drug dependence taskforce on prescription opioid non-medical use and abuse: position statement. Drug and Alcohol Dependence 69, 215-232.

Zarkin, G. A., M. T. French, T. A. Mroz, and J. W. Bray (1998). Alcohol and wages: New results from the national household survey on drug abuse. Journal of Health Economics 17, 53-68.